Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000.
Migliori GB, Centis R, Fattorini L, Besozzi G, Saltini C, Orefici G, Piersimoni C, Gori A, Cassone A; Italian Multicentre Study on Resistance to Antituberculosis drugs (SMIRA) Study Group. Migliori GB, et al. Among authors: centis r. Eur Respir J. 2003 Jan;21(1):129-34. doi: 10.1183/09031936.03.00047402. Eur Respir J. 2003. PMID: 12570121 Free article.
Evaluation of tuberculosis treatment results in Italy, report 1999.
Centis R, Migliori GB; Tuberculosis Study Group. National A.I.P.O. (Italian Association of Hospital Pneumologists); SMIRA Group (Multicentre Italian Study on Drug Resistance); National Tuberculosis Project, Istituto Superiore di Sanita. Centis R, et al. Monaldi Arch Chest Dis. 2002 Oct-Dec;57(5-6):297-305. Monaldi Arch Chest Dis. 2002. PMID: 12814046
First tuberculosis cases in Italy resistant to all tested drugs.
Migliori GB, De Iaco G, Besozzi G, Centis R, Cirillo DM. Migliori GB, et al. Among authors: centis r. Euro Surveill. 2007 May 17;12(5):E070517.1. doi: 10.2807/esw.12.20.03194-en. Euro Surveill. 2007. PMID: 17868596 Free article. No abstract available.
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?
Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Codecasa LR, Spanevello A, Cirillo DM; SMIRA/TBNET Study Group. Migliori GB, et al. Among authors: centis r. Eur Respir J. 2008 Apr;31(4):904-5. doi: 10.1183/09031936.00159807. Eur Respir J. 2008. PMID: 18378786 Free article. No abstract available.
Tuberculosis, one disease, many faces.
Migliori GB, Centis R, Lange C, Matteelli A, Cirillo D. Migliori GB, et al. Among authors: centis r. Monaldi Arch Chest Dis. 2008 Mar;69(1):2-4. doi: 10.4081/monaldi.2008.404. Monaldi Arch Chest Dis. 2008. PMID: 18507192 No abstract available.
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.
Migliori GB, Lange C, Centis R, Sotgiu G, Mütterlein R, Hoffmann H, Kliiman K, De Iaco G, Lauria FN, Richardson MD, Spanevello A, Cirillo DM; TBNET Study Group. Migliori GB, et al. Among authors: centis r. Eur Respir J. 2008 Jun;31(6):1155-9. doi: 10.1183/09031936.00028708. Eur Respir J. 2008. PMID: 18515555 Free article.
Reversing the tuberculosis upwards trend: a success story in Romania.
Marica C, Didilescu C, Galie N, Chiotan D, Zellweger JP, Sotgiu G, D'Ambrosio L, Centis R, Ditiu L, Migliori GB. Marica C, et al. Among authors: centis r. Eur Respir J. 2009 Jan;33(1):168-70. doi: 10.1183/09031936.00104308. Eur Respir J. 2009. PMID: 19118227 Free article.
239 results